FDA Grants Approval for First-Ever Pill To Tackle Postpartum Depression
[ad_1] The US Food and Drug Administration last week approved a pill for treating postpartum depression. The first oral treatment designed specifically for treating postpartum depression, Zurzuvae’s approval has been welcomed as a likely much cheaper, specific treatment for a condition that affects as many as one in seven people after they give birth. Dr. …
FDA Grants Approval for First-Ever Pill To Tackle Postpartum Depression Read More »